Cancer Research Horizons

#C-Further #Cancer research #Cancer Research Horizons #Children's Cancer

Why we need to rethink childhood cancer treatments

In this contribution to the Fall 2026 issue of DDW, Thomas Edwards, Partnering Lead for C-Further, examines why childhood cancer treatments lag behind adult treatments and what needs to change. Childhood cancer is one of the most underserved areas in oncology Cancer remains the leading disease-related cause of death in childhood,… Read More

#Cancer Research #Exclusive Content #Opinion

Neural networks
#AI / data analytics / healthtech / informatics #Cancer Research Horizons #Drug discovery #Francis Crick Institute #Medicines Discovery Catapult (MDC)

National programme to support data-driven health start-ups 

Applications have opened for a national accelerator programme supporting data-driven health innovation.  KQ Labs, led by the Francis Crick Institute and Medicines Discovery Catapult (MDC), is an annual five-month programme for early-stage companies building science-backed, scalable solutions in AI-driven drug discovery, digital health, and precision medicine. … Read More

#News

#Cancer Research Horizons #CAR T-cell therapy #Drug discovery #Oncology #UK

On the Horizon – will In Vivo CAR-T fulfil its potential? 

DDW’s Maria Wallace attended Cancer Research Horizons’ On the Horizon breakfast event to learn more about the latest opportunities and challenges in cancer drug discovery and development.  Leading experts from academia, pharma, biotech and investment met in London, UK Thursday 11 June to discuss the potential of in vivo CAR-T therapies to transform the future of… Read More

#News

#AI #ALS #Cancer Research Horizons #Cancer Research UK #FDA #Malaria #Mergers and acquisitions #Oncology #Real-time clinical trials #Regulatory #Spinogenix #University of Bath #University of Leeds

DDW Highlights: 12 May 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, the FDA advanced an initiative to implement real-time clinical trials. Elsewhere, UCB made… Read More

#Podcasts

#AI #ALS #Cancer Research Horizons #Cancer Research UK #FDA #Malaria #Mergers and acquisitions #Oncology #Real-time clinical trials #Regulatory #Spinogenix #University of Bath #University of Leeds

This week in Drug Discovery (4 – 8 May) 

News round-up for 4 – 8 May by Bruno Quinney, Content Team at DDW.  This week, the FDA has advanced an initiative to implement real-time clinical trials. Elsewhere, UCB has made headlines for through an acquisition and its cancer research venture.  The top stories:    FDA moves… Read More

#News

Modern medical science laboratory
#Cancer Research Horizons #Cancer Research UK #Oncology #UCB

Cancer research alliance to advance ‘life-changing’ therapies 

A global initiative is set to leverage oncology expertise to advance a pipeline of novel cancer therapies.  Biopharmaceutical company UCB has announced a new multi-project alliance with Cancer Research UK and its innovation arm, Cancer Research Horizons.   Under the new partnership, Cancer Research UK’s Centre… Read More

#Cancer Research #News

#Biosimilars #Cancer research #Cancer Research Horizons #Cerebral Palsy #Clinical trial #Crohn's disease #Depression #European Union #Novo Nordisk #Obesity #Psychedelics #Thermo Fisher Scientific #Ulcerative colitis (UC)

DDW Highlights: 24 February 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, researchers found an unexpected drug could help treat depression. Elsewhere, a new company is… Read More

#Podcasts

#Biosimilars #Cancer research #Cancer Research Horizons #Cerebral Palsy #Clinical trial #Crohn's disease #Depression #European Union #Novo Nordisk #Obesity #Psychedelics #Thermo Fisher Scientific #Ulcerative colitis (UC)

This week in Drug Discovery (16 – 20 February) 

News round-up for 16 – 20 February by Bruno Quinney, Content Team at DDW.  This week in DDW, an unexpected drug could help treat depression. Elsewhere, a new company is set to advance a cerebral palsy therapy.  The top stories:    Psychedelic drug could help treat depression … Read More

#News

#Cancer Research Horizons #Genome sequencing #RNA sequencing #UK

Oesophageal cancer dataset made available for commercial use 

Cancer Research Horizons has made one the largest oesophageal cancer datasets available for commercial licensing.  Developed by a team led by Professor Rebecca Fitzgerald at the University of Cambridge, the Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) dataset represents one of the world’s largest and most comprehensive collections… Read More

#Cancer Research #News

Trophy
#Awards #Cancer research #Cancer Research Horizons #Cancer Research UK

Cancer Research Horizons rewards innovation and entrepreneurship

Cancer Research Horizons, the innovation arm of Cancer Research UK, announced the winners of its third Innovation and Entrepreneurship Awards during an awards ceremony at Merchant Taylors’ Hall, London. Dr Alessia Errico, Associate Director of Search and Evaluation at Cancer Research Horizons, said: “These remarkable innovators demonstrate the determination and… Read More

#Cancer Research #News

Colorectal cancer
#Artificial intelligence (AI) #Cancer Research Horizons #Colorectal cancer #Multi-omics #Oncology

Partners develop AI tools to personalise colon cancer treatment

Cancer Research Horizons has announced a collaboration with Histofy to develop tools that predict how colorectal cancer patients respond to different treatment options using the multi-modal S:CORT dataset.  As part of the collaboration, Histofy will use digital pathology images, as well as clinical and molecular data, from the S:CORT dataset… Read More

#Business & Investment #Cancer Research #News

Scientist using a laptop
#Cancer Research Horizons #Laboratory data #Lifebit #Oncology

Partnership will open access to millions of cancer datasets

Cancer Research Horizons has joined Lifebit’s Federated Data Network to help maximise the impact of data generated through Cancer Research UK-funded research.   This federated network uses Lifebit’s Platform to ensure secure access to standardised datasets of millions of cancer patients from multiple international institutions for use in… Read More

#Cancer Research #News

Diamond Light Source's synchrotron
#Cancer Research Horizons #Diamond Light Source #Fragment-based drug discovery #Oncology #Partnership

UK partners establish fragment-based drug discovery programme

Cancer Research Horizons is partnering with Diamond Light Source, the UK’s national synchrotron, to build a world-leading fragment-based drug discovery programme.  Diamond Light Source accelerates electrons to near light speed, producing bright light that is directed into research instruments known as beamlines.   Cancer Research Horizons and its drug discovery site… Read More

#Business & Investment #Cancer Research #News

Saline intravenous (iv) drip in a child's hand
#Cancer Research Horizons #Drug discovery #LifeArc #Oncology #Paediatrics

Research consortium to focus on drug discovery for paediatric cancers

With an initial investment of £28 million in resources and funding, LifeArc and Cancer Research UK have launched a new initiative to develop medicines exclusively for children’s and young people’s cancers. C-Further will bring together researchers, clinicians, scientists and industry to provide support, finance and expertise. Read More

#Cancer Research #News

CRISPR gene editing
#AstraZeneca #Cancer Research Horizons #CRISPR #Genomics #Partnership

AZ and Cancer Research Horizons extend genomics partnership

Cancer Research Horizons and AstraZeneca have signed a five-year renewal of the Functional Genomics Centre, a facility dedicated to advancing drug discovery with genome-altering technologies such as CRISPR. The Functional Genomics Centre was established in 2019 to explore the function and interaction of genes and proteins… Read More

#News

#Allogene Therapeutics #allogeneic cell therapies #Biologics #Biotech #Cancer Research Horizons #Cancer vaccine #CAR-T #Cell therapy #Clinical trials #Drug discovery #Financing #Funding #LifeArc #Oncology #Rare disease #Research and development #Seed funding #Start-ups #University of Dundee #University of Oxford

New DDW Highlights episode: 8 May 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The ongoing innovation and development in the drug discovery sector relies on a number… Read More

#News